Work

THU0043 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events

Year: 2018

Type: article

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2018-eular.2383

Authors: P. Budde, J.L. Marte, H.-D. Zucht, S. Bhandari, M. Tuschen, P. Schulz-Knappe, R.A. Madan, J.L. Gulley, J. Schlom

Institutions: Protagen (Germany), National Institutes of Health, National Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2901401358

FWCI: 0.254

Cites: 1

Cited by: 4

Related to: 10